+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist



Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist



Journal of Medicinal Chemistry 23(6): 594-595




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042303827

Download citation: RISBibTeXText

PMID: 7392026


Related references

Aporphines. 30. (-)-N-(2-Chloroethyl)-10,11-dihydroxynoraporphine (chloroethylnorapomorphine), novel irreversible dopamine receptor antagonist. Journal of Medicinal Chemistry 23(6): 594-595, 1980

Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist. Journal of Medicinal Chemistry 26(10): 1348-1353, 1983

On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms. Journal of Pharmacy and Pharmacology 32(8): 571-576, 1980

Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application. Journal of Medicinal Chemistry 27(6): 806-810, 1984

Aporphines. 58. N-(2-Chloroethyl)[8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application. Journal of Medicinal Chemistry 27(6): 806-810, 1984

Evaluation of structural effects on 5-HT(2A) receptor antagonism by aporphines: identification of a new aporphine with 5-HT(2A) antagonist activity. Bioorganic and Medicinal Chemistry Letters 24(7): 1664-1667, 2015

Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro. European Journal of Pharmacology 67(1): 105-110, 1980

Aporphines part 16 action of aporphine alkaloids on loco motor activity in rats with 6 hydroxy dopamine lesions of the nucleus accumbens. European Journal Of Pharmacology: 85-92, 1976

(-)N-(chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor binding. Nature 285(5766): 571-573, 1980

Levo n chloroethyl norapomorphine inhibits striatal dopamine function via irreversible receptor binding. Nature (London) 285(5766): 571-573, 1980

Studies on pro aporphine and aporphine alkaloids part 6 synthesis of racemic glaziovine by spiran ring construction on a cyclo pent ij iso quinoline stereochemistry of reduced pro aporphines. Journal of the Chemical Society Perkin Transactions I (17): 1652-1658, 1975

Aporphines part 14 dopaminergic and anti nociceptive activity of aporphine derivatives synthesis of 10 hydroxy aporphines and 10 hydroxy n n propyl noraporphine. Journal Of Medicinal Chemistry: 25-29, 1976

Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. Journal of Medicinal Chemistry 24(12): 1440-1445, 1981

Studies on pro aporphine and aporphine alkaloids part 7 stereochemistry of reduced pro aporphines of croton sparsiflorus and croton linearis. Journal of the Chemical Society Perkin Transactions I (17): 1659-1663, 1975

Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist. Neuroscience 32(3): 769-778, 1989